FDA Commissioner Marty Makary is said to be pushing back at an effort from the White House to remove one of his top aides.
The White House is apparently unhappy that Associate Director of Policy and Research Strategy Sanjula Jain-Nagpal had told FDA stakeholders she is also Makary’s deputy chief of staff, a role that the Trump administration has yet to approve, POLITICOreported.
Makary and Jain-Nagpal are known to be close as they both have connections to Johns Hopkins University.
The latest dustup involving the commissioner comes after a report earlier this month that HHS Secretary Robert F. Kennedy Jr. considered limiting Makary’s role and having someone else manage day-to-day FDA operations due to disagreements over his management style.
Dear readers: We recognize that politics often intersects with the financial news of the day, so we invite you to click here to join the separate political discussion.
